U.S. judge upholds validity of Eli Lilly’s Alimta patent

[Reuters] – Eli Lilly was successful in a crucial legal battle on Monday when a U.S. District Judge in Indianapolis upheld the validity of its U.S. patent for the drugmaker’ s blockbuster lung-cancer drug, Alimta. The court said the defendants, Teva Phar more

View todays social media effects on LLY

View the latest stocks trending across Twitter. Click to view dashboard

See who Eli is hiring next, click here to view